Why the study?
Does pharmacist-managed antiarrhythmic drug therapy monitoring reduce costs and improve efficiency compared to usual care in an EP program?
Does pharmacist-managed antiarrhythmic drug therapy monitoring reduce costs and improve efficiency compared to usual care in an EP program?
Pharmacist-managed antiarrhythmic drug monitoring in an outpatient clinic provides cost savings and improves EP program efficiency by freeing up physician time.
Answers are grounded in this paper and cite their sources.
May support pharmacist integration in EP programs; leaves open need for randomized confirmation of benefits.
PURPOSE: The economic impact of pharmacist-managed antiarrhythmic drug therapy monitoring on an academic medical center's electrophysiology (EP) program was investigated. METHODS: Data were collected for the initial two years of patient visits (n = 816) to a pharmacist-run clinic for antiarrhythmic drug therapy monitoring. A retrospective cost analysis was conducted to assess the direct costs associated with three appointment models: (1) a clinic office visit only, (2) a clinic visit involving electrocardiography and basic laboratory tests, and (3) a clinic visit including pulmonary function testing and chest x-rays in addition to electrocardiography and laboratory testing. A subset of patient cases (n = 18) were included in a crossover analysis comparing pharmacist clinic care and usual care in an EP physician clinic. The primary endpoints were the cost benefits and cost savings associated with pharmacy-clinic care versus usual care. A secondary endpoint was improvement of overall EP program efficiency. RESULTS: The payer mix was 61.6% (n = 498) Medicare, 33.2% (n = 268) managed care, and 5.2% (n = 42) other. Positive contribution margins were demonstrated for all appointment models. The pharmacist-managed clinic also yielded cost savings by reducing overall patient care charges by 21% relative to usual care. By the second year, the pharmacy clinic improved EP program efficiency by scheduling an average of 24 patients per week, in effect freeing up one day per week of EP physician time to spend on other clinical activities. CONCLUSION: Pharmacist monitoring of antiarrhythmic drug therapy in an out-patient clinic provided cost benefits, cost savings, and improved overall EP program efficiency.
No takes yet. Share an insight, caveat, or question.
Snider et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: